-       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €1436EUR$1,600USD£1,260GBP 
      €1795EUR$2,000USD£1,575GBP 
                  -       Clinical Trials 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1077EUR$1,200USD£945GBP 
      €1346EUR$1,500USD£1,181GBP 
                  -       Clinical Trials 
   - April 2025
    -  90 Pages 
    Global
   
   From       €1795EUR$2,000USD£1,575GBP 
      €2243EUR$2,500USD£1,969GBP 
                  -       Report 
   - December 2024
    -  47 Pages 
    Global
   
   From       €2836EUR$3,160USD£2,489GBP 
      €3544EUR$3,950USD£3,111GBP 
                  -       Report 
   - December 2024
    -  84 Pages 
    Global
   
   From       €2836EUR$3,160USD£2,489GBP 
      €3544EUR$3,950USD£3,111GBP 
                   -       Report 
   - August 2025
    -  141 Pages 
    Global
   
   From       €2287EUR$2,549USD£2,008GBP 
      €2691EUR$2,999USD£2,362GBP 
                -       Report 
   - April 2025
    -  183 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                -       Report 
   - March 2025
    -  182 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                -       Report 
   - April 2025
    -  218 Pages 
    Global
   
   From       €2243EUR$2,500USD£1,969GBP 
                -       Report 
   - January 2025
    -  192 Pages 
    Global
   
   From       €2243EUR$2,500USD£1,969GBP 
                  -       Report 
   - October 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
                  -       Report 
   - October 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
                  -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                  -       Report 
   - March 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - August 2025
    -  145 Pages 
    Global
   
   From       €3544EUR$3,950USD£3,111GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2422EUR$2,699USD£2,126GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2422EUR$2,699USD£2,126GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2503EUR$2,789USD£2,196GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2503EUR$2,789USD£2,196GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4441EUR$4,949USD£3,898GBP 
             
          The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive.
The market is highly competitive, with many companies vying for market share. Companies in the market    include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less   Read more